1. Home
  2. JYNT vs RGC Comparison

JYNT vs RGC Comparison

Compare JYNT & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • RGC
  • Stock Information
  • Founded
  • JYNT 2010
  • RGC 2014
  • Country
  • JYNT United States
  • RGC Hong Kong
  • Employees
  • JYNT N/A
  • RGC N/A
  • Industry
  • JYNT Multi-Sector Companies
  • RGC Medicinal Chemicals and Botanical Products
  • Sector
  • JYNT Miscellaneous
  • RGC Health Care
  • Exchange
  • JYNT Nasdaq
  • RGC Nasdaq
  • Market Cap
  • JYNT 154.2M
  • RGC 105.3M
  • IPO Year
  • JYNT 2014
  • RGC 2021
  • Fundamental
  • Price
  • JYNT $10.22
  • RGC $4.86
  • Analyst Decision
  • JYNT Strong Buy
  • RGC
  • Analyst Count
  • JYNT 2
  • RGC 0
  • Target Price
  • JYNT $17.50
  • RGC N/A
  • AVG Volume (30 Days)
  • JYNT 50.4K
  • RGC 8.8K
  • Earning Date
  • JYNT 03-06-2025
  • RGC 10-25-2024
  • Dividend Yield
  • JYNT N/A
  • RGC N/A
  • EPS Growth
  • JYNT N/A
  • RGC N/A
  • EPS
  • JYNT N/A
  • RGC N/A
  • Revenue
  • JYNT $120,795,620.00
  • RGC N/A
  • Revenue This Year
  • JYNT $3.28
  • RGC N/A
  • Revenue Next Year
  • JYNT N/A
  • RGC N/A
  • P/E Ratio
  • JYNT N/A
  • RGC N/A
  • Revenue Growth
  • JYNT 5.26
  • RGC N/A
  • 52 Week Low
  • JYNT $8.94
  • RGC $3.03
  • 52 Week High
  • JYNT $17.82
  • RGC $32.44
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 42.53
  • RGC 44.96
  • Support Level
  • JYNT $9.98
  • RGC $4.75
  • Resistance Level
  • JYNT $10.81
  • RGC $5.21
  • Average True Range (ATR)
  • JYNT 0.43
  • RGC 0.30
  • MACD
  • JYNT 0.02
  • RGC 0.04
  • Stochastic Oscillator
  • JYNT 50.00
  • RGC 23.87

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: